In the modern world of drug development, given continually rising R&D costs, the increasing complexity of trials, and ever-higher hurdles to regulatory approval, both sponsors and CROs are being forced to think differently about how to derive maximum value from their working relationship.
|In response, INC Research envisions a networked model in which sponsors, investors, CROs, and other service providers all work in strategic partnership to improve the speed, efficiency, and quality of drug development. |
INC Research is at the forefront of a movement in which sponsors and CROs are working together to question the existing model, and create new models in which sponsors and CROs act as true partners with shared goals to form alliance partnerships.
INC Research is uniquely positioned to build these kinds of alliance partnerships with our clients. We focus exclusively on Phase I through Phase IV clinical trials, and we have strategic expertise in pipeline management, registration strategies, compliance, due diligence, and other aspects of the drug development and commercialization continuum.
The concept of strategic alliances between sponsors and CROs is in its infancy. And, like any new idea, there will be models that work and models that don’t. INC Research has created a team focused solely on structuring and managing successful alliance relationships, because we know that by working closely with our customers and applying best practices and first-hand experience of their unique program requirements, our team collaborates to develop “fit for purpose” solutions.
No matter how the alliance partnership is structured, the following benefits apply:
- Shared Risk
- Cost Savings
- Resource Commitment
- Creative Thinking
Based on our experience thus far, we are confident that through our exploratory process we can structure a working relationship that drives benefits in quality, consistency, efficiency, and the bottom line—far beyond what’s possible in a tactical outsourcing relationship. Together, with our alliance partners, we can help advance the sponsor-CRO relationship to realize the true value of strategic outsourcing.
For more information on INC Research’s Alliance Partnership’s programs, click here.
Download our NEW white paper:|
Win with Networked Drug Development Alliances: New Strategies to Increase Productivity and Mitigate Risk